Biotest AG (HAM:BIO) Construction In Progress: €0.0 Mil (As of Mar. 2025)


HAM:BIO Biotest AG HAM:BIO
56 GF Score
Price €40.00
View Full Analysis

What is Biotest AG Construction In Progress?

Biotest AG HAM:BIO +2.04% 56 Construction In Progress is €0.0 Mil as of Mar. 2025. GuruFocus rates HAM:BIO with a GF Score™ of 56/100.

Biotest AG's quarterly construction in progress increased from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€85.5 Mil) but then declined from Dec. 2024 (€85.5 Mil) to Mar. 2025 (€0.0 Mil).

Biotest AG's annual construction in progress increased from Dec. 2022 (€87.5 Mil) to Dec. 2023 (€102.7 Mil) but then declined from Dec. 2023 (€102.7 Mil) to Dec. 2024 (€85.5 Mil).

Biotest AG Construction In Progress Historical Data

* Premium members only.

The historical data trend for Biotest AG's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest AG Construction In Progress Chart

Biotest AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 237.00 73.30 87.50 102.70 85.50

Biotest AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 85.50 0.00
HAM:BIO
56GF Score
Biotest AG HAM:BIO
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotest AG Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €0.0 Mil mean?
Biotest AG (HAM:BIO) has a Construction In Progress of €0.0 Mil as of Mar. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Biotest AG and its competitors.
Is Biotest AG's Construction In Progress too high?
Biotest AG's current Construction In Progress is €0.0 Mil. Overall, Biotest AG has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Biotest AG's Construction In Progress compare to VRTX and REGN?
Biotest AG's Construction In Progress of €0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Biotest AG and its competitors. Biotest AG's current Construction In Progress is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotest AG stock overvalued right now?
Biotest AG (HAM:BIO) has a current Construction In Progress of €0.0 Mil. The current Construction In Progress is €0.0 Mil. Biotest AG's overall GF Score™ is 56/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Biotest AG (HAM:BIO), the current Construction In Progress is €0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotest AG Business Description

Address Landsteinerstrasse 5, PO Box 10 20 40, Dreieich, DEU, 63303
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The company covers preclinical and clinical development of the preparations, plasma collection, production, as well as marketing and sales.
56GF Score

Get the complete analysis for HAM:BIO

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€40.00
Price